Scholarly Index
Rabih Halwani
University of Sharjah; 45,174 total citations; 295 total publications; best world rank #51
University of Sharjah
45,174Total citations
295Total publications
75H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| COVID-19 Clinical Research Studies | Lifetime | 203 | AE 1 | 98.99 |
| Long-Term Effects of COVID-19 | Lifetime | 151 | AE 1 | 98.44 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 843 | AE 1 | 97.41 |
| IL-33, ST2, and ILC Pathways | Lifetime | 714 | AE 2 | 93.83 |
| COVID-19 Clinical Research Studies | 2021-2025 | 64 | AE 1 | 99.55 |
| Long-Term Effects of COVID-19 | 2021-2025 | 51 | AE 1 | 99.12 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 497 | AE 1 | 97.96 |
| COVID-19 and Mental Health | 2021-2025 | 739 | AE 4 | 94.31 |
| Inflammasome and immune disorders | 2021-2025 | 536 | AE 2 | 87.26 |
| interferon and immune responses | 2021-2025 | 782 | AE 2 | 82.31 |
| Vitamin D Research Studies | 2021-2025 | 540 | AE 10 | 80.78 |
| S100 Proteins and Annexins | 2021-2025 | 392 | AE 3 | 73.87 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 809 | AE 3 | 75.98 |
| Vitamin C and Antioxidants Research | 2021-2025 | 323 | AE 6 | 74.35 |
| Dermatological and COVID-19 studies | 2021-2025 | 356 | AE 2 | 66.88 |